Lynch Regenerative Medicine, LLC., (LRM) announced today that it has acquired exclusive rights to REGRANEX® gel and recombinant purified platelet-derived growth factor (PDGF) from Smith & Nephew, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback